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ABSTRACT 
The analysis of anabolic steroids at low concentrations presents a major problem in many 
analyt_~cal laboratories. The need for a better detection limit requires improvements in 
I 
currently used analytical methods. Although sensitive instruments e.g. HRMS are available 
for the trace analysis of steroids, improvement in sample preparation has not received 
much attention. In the present study, two sample preparation methods i.e. direct hydrolysis 
and immunoaffinity extraction (IAE) are evaluated in order to improve analytical 
performance. Various SPE cartridges were studied for direct hydrolysis and mixed mode 
cartridges (C8/SAX) showed comparable recoveries for clenbuterol, norandrosterone, 
17a-methylandrostanediol and 3-hydroxystanozolol to that obtained from indirect 
hydrolysis, i.e. 61.6 %, 75.3 %, 88.3% and 90.9% for indirect hydrolysis and 65.1 %, 
74.6 %, 92.2 % and 86.1 % for direct hydrolysis respectively. However, when the urine 
background becomes dirtier, indirect hydrolysis was more robust. 
An immunoaffinity gel was developed with antibodies raised against 17a-MT and 
immobilized on to· Sepharose gels. The immunogen was synthesized using mixed 
anhydride method. The antisera having the relatively higher titre value among the antisera 
obtained were used for subsequent study. The antibodies were raised in rabbits and showed 
cross-reactivity with a few structurally similar steroids. Especially those steroids having a 
17a-methyl group such as metendienone, mestanolone, 17a-methylandrostandiol and 
stanozolol were cross-reacted with 17a-MT (33.0 %, 22.6 %, 14.1 % and 8.3 % 
respectively). Those steroids that lack the 17a-methyl group had poor cross-reactivity. The 
xviii 
optimal solvent conditions for washing and elution of 17a.-MT were studied using the · 
immunoaffinity gel. It was found that 30 % and 70 % methanol in water was the best 
\Vashing and elution solvents respectively and extraction efficiency of 98.9 % 17a.-~T 
could :be achieved. The binding capacity for the gel was detennined as 800 ng 17a.-MT. 
Subsequently, this IAE was evaluated using individual urinary samples spiked with I 7a-
MT, 17a-methylandrostandiol and 3-hydroxystanozolol. The gels showed relatively good 
recoveries towards 17a-MT (86.37 %), 17a-methylandrostandiol (62.14 %) as well as 3-
hydroxystanozolol (50.25 %). Full scan mass spectra of the extracts showed relatively 
cleaner backgrounds, making them suitable for confinnatory analysis at concentrations as 
low as 5 ng/ml. 
XIX 
KAEDAH PENGESTRAKAN FASA PEPEJAL DAN IMMUNOAFFINITI DALAM 
ANALISIS STEROID-STEROID 17a-METIL 
ABS~RAK 
Analisis steroid-steroid anabolic pada kepekatan rendah merupakan satu masalah utama 
yang hadir dalam kebanyakan makmal analitikal. Keperluan untuk satu had pengesanan 
yang lebih baik memerlui pembaikan-pembaikan dalam kaedah analitikal yang diguna 
padam~sa kini. Wala4pun instrumen-instrumen yang sensitive seperti HRMS sedia ada 
·- ·- -. .. .: 
untuk analisis pengesanan steroid-steroid, tetapi pembaikan dalam penyediaan sampel 
tidak menerima banyak perhatian. Dalam pelajaran masa sekarang, dua kaedah penyediaan 
sampel iaitu hidrolisis secara langsung dan pengestrakan immunoaffiniti telah dinilaikan 
supaya membaiki perlaksanaan analitikal. Pelbagai kartus fasa pepejal (SPE) telah 
dipelajari untuk hidrolisis secara langsung dan kartus mod bercampur (C8/SAX) 
menunjukkan pemulihan yang setanding untuk clenbuterol, norandrosterone, 17a-
methylandrostanediol dan 3-hydroxystanozolol kepada yang didapati daripada hidrolisis 
. . 
seca'ra tidak langsung, iaitu 61.6 %, 75.3 %, 88.3% dan 90.9% untuk hidrolisi secara tidak 
langsung dan 65.1 % , 74.6 %, 92.2 % dan 86.1 % untuk hidrolisis secara langsung 
masing-masing. Akan tetapi, apabila latar belakang air kencing menjadi lebih kotor, 
hidrolisis secara tidak langsung adalah lebih tegap. 
Satu gel immnoaffiniti telah dibinakan dengan antibodi yang dibangkit bertentangan 
dengan 17a-methyltestosterone dan ditetapkan pada gel-gel Sepharose. Immunogen telah 
XX 
disintesiskan dengan kaedah 'anhydride' bercampur. Antisera mempunyai nilai 'titre' yang · 
Jebih tinggi berbanding dengan antisera-antisera yang diperolehi telah digunakan untuk 
pelajaran selanjutnya. Antibodi-antibodi ini dibangkit dalam amab dan menunjukkan 
reaktivi bersilang dengan beberapa steroid yang dengan strukturalnya seakan-akan sama. 
Terutamanya, steroid-steroid yang mempunyai satu kumpulan 17a-metil seperti 
metanedienone. mestanolone, 17a-methylandrostanediol dan 3-hydroxystanozolol adalah 
bertindak silang dengan 17a-methyltestosterone (17a-MT) (33.0 %, 22.6 %, 14.1 %dan 
8.3 % masing-masing). Steroid-steroid yang kekurangan kumpulan 17a-metil mempunyai 
reaktivi bersil<;mg.yang kurang. Syarat solven (pelarut) yang optimal untuk membasuh dan 
elusi mengenai 17a-methyltestosterone telah dipelajari menggu:1akan gel immunoaffiniti 
ini. Ini adalah didapati bahawa 30 %dan 70 % metanol dalam air masing masing adalah 
solven pembasuhan dan elusi yang terbaik dan 98.9% kecekapan pengestrakan mengenai 
I 7a-methyltestosterone boleh dicapai. Kemampuan pengikatan untuk gel ini telah 
ditentukan pada 800 ng 17a-methyltestosterone. Seterusnya, pengestrakan immunoaffiniti 
ini telah dinilaikan dengan mengguna sampel-sampel air kencing yang individu dicampur 
dengan 17a-methyltestosterone, 17a-methylandrostanediol dan 3-hydroxystanozolol. Gel-
gel ini menunjukkan pemulihan-pemulihan yang baik terhadap 17a-methyltestosterone 
(86.3 7 %), 17a-methylandrostanediol (62.14 %) dan 3-hydroxystanozolol (50.25 %). 
Spektra jisim sekali lintas penuh (full scan) untuk ekstrak-esktrak ini telah menunjukkan 
latar belak.ang yang lebih bersih supaya menjadikan mereka sesuai diguna untuk tujuan 
pengesahan pada kepekatan yang rendah seperti 5 ng/ml. 
xxi 
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CHAPTER 1: INTRODUCTION 
1.1 Doping Control In Sport 
The use of drugs to enhance performance in sport is not a new phenomenon but one 
that has been known since the time of the ancient Greeks. In the early 1960s, the 
Council of Europe banned the use of endogenous or exogenous agents which help to 
achieve an artificial and unfair increase in performance of the athlete in competition 
so that a ''level playing field" can be achieved (Bowers and Segura. 1996). In 1967. 
the International Olympic Committee (IOC) re-established a medical commission 
\vhose major responsibility is to control drug abuse in sport. This was followed by the 
introduction of drug testing in 1968 (Gower et a/., 1995). The frrst drug testing 
activity \vas carried out at the 1972 Olympic Games in Munich, where gas 
chromatography with nitrogen-selective detectors were used to test more than 2000 
urine specimens for stimulants (Bowers. 1997). 
1.2 Abuse Of Anabolic Steroids In Sport 
By 1968, the use of anabolic steroids among athletes was common. In that year, a 
decathlon athlete claimed that an estimated one third of the US track and field team 
had used steroids at the pre-Olympic training camp before the Mexico City Games. At 
that time, anabolic steroids were not included in the banned class of compounds 
because there was no proper testing method available (Cowan and Kiernan. 1997). 
With the successful introduction of a radioimmunoassay screen for anabolic steroids 
and a GC-MS method for confim1atory purposes. a trial test was introduced at the 
Commonwealth Games in New Zealand in February 1974. Out of 55 samples 9 failed 
the screening test and 7 samples were confirmed positive. The current groups of drugs 
that are banned have been expanded to include anabolic agents. stimulants. narcotics, 
P-blockers. diuretics. peptide hormones and theirs analogues (Cowan and Kiernan, 
1997). Recent statistics from the IOC accredited laboratories indicates that anabolic 
steroids remain the primary performance-enhancing substances detected in athletes 
(Bowers, I 997) . 
. Lately. the detection of prohibited substances has become increasingly difficult. This 
is due to the aYailability of numerous potent synthetic steroids and the increasing 
number of dietary supplements used by athletes as well as the pharmacological 
sophistication of drug use (Wu, 1997). 
Anabolic steroids are usually taken for a number of weeks before an important contest 
(Wu. 1997). Several anabolic steroids may be administered simultaneously both orally 
and by injection. This procedure is known as "stacking". The weekly dose is five to 
ten times the manufacturer's recommended therapeutic dose (Wu, 1997). Doses will 
Qften follow a '·pyramid'' program where maximum amounts are being administered 
in the middle or at the end of a cycle of steroid administration (Wilson, 1988). 
Therefore. the implementation of "no-notice'' testing (while out of competition) in 
addition to competition testing of athletes is necessary in order to minimize the 
opportunity of getting benefit from the banned drugs (Bowers. 1997). Diuretics are 
also commonly used to mask the appearance of the drug from their sample through 
dilution and forced diuresis (Mueller eta!., 1995). 
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To catch the defaulters during any competition, very sensitive and reliable analytical 
methods are needed. Therefore, the desire of improvement or development in 
analytical methods and sample preparation is of prime importance in most IOC 
accredited laboratories. One of the thrust areas of this development is to achieve the 
,. 
detection limit of 2 ngiml for various anabolic steroids in order to achieve better 
retrospecificity. Recent advances in mass spectrometry. for instance. use of HRMS 
have provided an opportunity to decrease the detection limits _of these agents, 
culminating in the use of HRMS for steroid screening at the Summer Olympic Games 
m 1996 (Homing eta! .. 1997). 
1.3 Adverse Effects Of Anabolic Steroids 
The health hazards induced by anabolic steroids administration have been extensively 
reviewed. The adverse effects may be manifested with pharmacologically 
recommended doses but is of much greater consequence for those who administer 
excessive amounts over long periods of time, as is done in sports. 
The adverse effects of anabolic steroids abuse depend on the age, sex of the 
. 
individual, the duration, total dose and the type of steroid used. These effects may be 
differentiated into androgenic or toxic effects. The former effects are amplification of 
the physiological effects of androgens (discussed in section 1.4.2.1), whereas the 
latter effects are regarded to have more serious consequences (Wu. 1997). The toxic 
effects of anabolic steroids are listed in Table 1.1. 
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Table 1.1. The toxic adverse effects of anabolic steroids at different target systems. 
Target system Adverse effects 
"d. Cardiovascular I. Cardiomyopathy 
II. Acute mycocardial infarct 
... Cerebral vascular accident Ill. 
IV. Pulmonary embolism 
.2. Liver I. Cholestatic jaundice 
II. Peliosis hepatis 
... 
Tumour Ill. 
3. Psychological I. Aggression increased 
II. Dysphoria -rage 
... 
Psychosis III. 
IV. Addiction 
V . Withdrawal effects-depression 
. 
One of the most serious problems associated with anabolic steroids abuse is the 
decrease in circulating HDL-cholesterol because of the action of androgens in 
suppressing hepatic endothelial lipase activity. This may have long-tenn 
consequences in increasing the risk to ischemic heart disease (Wu, 1997). 
Sustained suppression of hypothalamic-pituitary-gonadal axis can cause prolonged 
infe11ility, testicular atrophy and secondary amenorrhea. In women, some of the 
effects of virilization may be irreversible, e.g. deepening of the voice and clitoral 
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hypertrophy. Liver dysfunction and hepatotoxicity are associated with the l,lSe of the 
17a-alkylated steroids. Sustained side effects of anabolic steroids observed in human 
included effects on liver, cardiovascular and reproductive system and premature 
epiphyseal cell closure (Gower et al .. 1995). 
" I 
1.4 Anabolic Steroids (Androgens) 
1.4.1 Structure and nomenclature 
Anabofic steroids most frequently used by athletes are synthetic male sex honnones. 
the androgens. The androgens comprise a group of C19 steroids derived from 
cholesterol, which has the basic steroid molecular skeleton made up of four rings of 
carbon atoms, labeled as A-D. Their hydrocarbon structure con·esponds to 
androsTane. Almost all natural steroids possess either one or more. usually two methyl 
(CH3) groups at positions 18 and 19 in the a-configuration. However, if only one 
methyl group is present at position I 8, the structure is estrane, i.e. structure for 
steroidal hornwne oestrogen (Kirk et al., 1995). The molecular structure for the 
s!eroid skeleton is shown in Figure I. I. 
Androgens such as testosterone possess both androgenic and anabolic activities. In 
male athletes, enhancement in performance may be due to an indirect anabolic effect 
of steroids via the androgenic effects in increasing aggression and competitiveness 
(Brooks. 1978). Hence, the more accurate term for anabolic steroids is anabolic-
a:tdrogenic steroids but for simplicity the shorter term is used in this chapter. 
'"' I 
2 
3 
18 
4 6 
Figure 1.1. The molecular structure of the steroid skeleton. 
1.4.1.1 Relationship of structure and androgenicity 
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For a C1q steroid to be an androgen, a 17-oxygen function should be present with, 
either the 4-en-3-oxo configuration as in testosterone or a 3-oxo-group with a 
saturated A ring as in 5a-dihydrotestosterone (5a-DHT) (Figure 1.2). If the 
17 -oxygen function is absent, as in4, 16-androstanedien-3-one, androgenic activity is 
completely lost (Gower, 1972). In addition, if a 17-hydroxyl group ( -OH) appears in 
the structure. it can be presented in either a- or P- configuration. For instance, those 
steroids with 17P-hydroxyl group as in testosterone and 5a-DHT mainly are steroids 
wit:1 relatively high androgenic activity. Alternatively, if a 17 a-hydroxyl group is 
present as in epitestosterone, the steroids concerned have little or no androgenicity. If 
oxidation of the 17P-hydroxyl group occurs to give a 17 -oxosteroid, as in the case of 
testosterone being converted to 4-androstenedione or 5a-DHT to Sa-androstane-
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3,17-dione, then androgenicity may be respectively much reduced or completely lost 
(Gower and Fotherby, 1975). 
The major naturally occurring androrens are testosterone, 5a-DHT and ·, 
5a-androstane-3a, 17[3-diol. Besides, there are 4-androstenedione and 
dehydroepiandrosterone (DHA) which only have weak androgenic activity. With the 
purpose of maximizing the anabolic effect and minimizing the androgenic activity of 
anabolic steroids, many modifications on testosterone molecule have been 
undertaken. Some of the major stmctural modifications have been introduced into 
testosterone or 5a-DHT is as follows (Gower et. a!., 1995): -
(i) Introduction of a second double bond into the A-ring, e.g. boldenone. 
(ii) Attachment of a-alkyl substituents at the 17-position in case of orally active 
anabolic agents. e.g. methandienone. 
(iii) Attachment of a pyrazole ring to the A-ring, e.g. stanozolol. 
(iv) Attachment of an oxymethylene group at C-2, e.g. oxymetholone. 
(v) Replacement of the C -2 carbon in the A-ring with oxygen, e.g. oxandrolone. 
(yi) Substitution of a chlorine atom or hydroxy group at C-4, · e.g. in 
4-chloromethandienone, oxymesterone (Figure 1.2.). 
,.· 
~ HcJ 
Testosterone 
OH 
OH 
5a.-Androstane-3a, 17P-diol 
OH 
Methanedienor e 
- 8-
OH 
5a-Dihydrotestosterone (5a-DHT) 
0 
,.· 
HO~ 
Dehydroepiandrosterone (DHA) 
OH 
HO 
Oxymesterone 
Figure 1.2. Structures of some maJor naturally occurnng and authentic anabolic 
steroids. 
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OH 
OH 
Stanczolol Mestanolone 
OH OH 
Boldenone Oxandrolone 
0 OH 
0 
Cl 
4-Androstenedione 4-Chloromethanedienone 
Figure 1.2 (contd.). Structures of some maJOr naturally occumng and synthetic 
anabolic steroids. 
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1.4.2 Pharmacology of androgens 
1.4.2.1 Physiological actions and effects 
Androgens are largely secreted by the Leydig ::ells of the interstitial tissue of the 
testes and to a lesser extent by the adrenals and ovaries. These androgens are required 
life long in males and are responsible for the differentiation and development of the 
male reproductive activities and male secondary sex char.:~cteristics, as well as the 
maintenance of these male qualities ("maleness''). 
The numerous diverse effects of the androgens manifest most clearly at puberty, such 
as the maintenance of the normal function and structure of the prostate gland and 
seminal vesicles. in particular with spermatogenesis (Sh.:~rpe et. a!., I 990). The 
androgens also possess some effects on non-sexual organs and tissues, for example, 
stimulated growth of pubic, facial hair and enhanced the deepening of the voice 
because of enlargement of larynx and thickening of the vocal cords. The anabolic 
effects of androgens are also noted in muscle mass and bone in giving rise to 
i!lcreased height and weight at puberty (Gower, 1979), In addition, androgens also 
demonstrate the activation of sexual behavior in the male during adolescence and 
young adult life (Wu, I 997). 
1.4.2.2 Biosynthesis of andre gens 
Much of our knowledge on the biosynthesis pathways of androgen is obtained from 
incubation studies with relatively large quantities of steroid precursors such as 
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pregnenolone and progesterone and then analyzing the metabolites formed 
(Slaunwhite eta/., 1965; Kwan et al., 1984). 
As a result of a great number of in vivo and in vitro studies. it appears that there are -, 
two pathways for androgen biosynthesis from the pregnenolone. One of these 
involves S-ene-3P-hydroxysteroid metabolites such as 17 -hydroxypregnenolone and 
DHA and is called the '·5-ene-Jp-hydroxy'' pathway. \Vhile the other involves 
17-hydroxyprogesterone is called the "4-ene-Joxo .. pathway. They are sometimes 
referred to as the 6 5 and the 6 ~ pathways. respectively to indicate the positions of 
unsaturation in the relevant intermediates (Slaunwhite et a! .. 196S). Both pathways 
are shown in Figure 1.3 (Gower, 199S). 
1.4.2.3 Metabolism of anabolic steroids 
The metabolism of some of the common anabolic steroids was investigated as early as 
the 19SOs. In humans, anabolic steroids are extensively metabolized and being 
excreted in the urine with little or unchanged parent drug. The pathways elucidated 
involve oxidation, reduction. hydroxylation and epimerization (phase l reactions), and 
conjugation reaction with uridinediphosphate glucuronic acid (UDPGA) and 
phosphoadenosine phosphosu lphate (PAPS) (phase 2 reactions). 
In humans, phase 1 reactions mainly involve reduction in the A-ring. yielding both the 
Sa- and sp-isomers whereas reduction at C -3 gives predominantly the 3a-isomers. 
Oxidation at C -17 occurs without subsequent reduction in the case of nandrolone in 
man, the major metabolites obtained are Sa- and sp- isomers of 3a-hydroxyestran-
- 12-
17-one i.e. norandrosterone and noretiochlolanolone, respectively (Masse et al .. 
1989a). 
Besides natural occumng steroids, synthetic st~roids like stanozolol and 
...... __ _ 
r 
17a-methyltestosterone also undergo metabolism in order to produce their major 
metabolites. For instance, the hydroxylation of stanozolol occurs at position C-3. C-4 
and C-16 produces a series of mono- and di-hydroxy metabolites. Among them, 
3-hydroxystanozolol is one of the major metabolite for stanozolol (Masse et al .. 
1989b). In metabolism study of 17a-methyltestosterone. the analysis of metabolites 
revealed that with reduction of the A-ring and the 3-oxo group. 17a-
methylandrostandiol (Schoene eta!., 1994) was produced as its major metabolite. The 
metabolisms of nandrolone, stanozolol, 17 a-methyltestosterone and their major 
metabolites in human urine are shown in Figure 1.4. 
The mechanisms of phase 2 reactions involve conjugation with UDPGA to yield 
glucuronides and with PAPS to yield sulphates. Anabolic steroids and their 
metabolites appear in the urine almost exclusively as water soluble glucuronide or 
sulphate conjugates. Steroids having a 3P-hydroxyl group are excreted mainly as 
sulphates, while Ja-hydoxysteroids are excreted as P-glycosidically linked 
glucuronides. 
~ !!_-. 
H 
ll II 
Pregnelonenolone 
~ 17-Hydroxypregnenolonc ~ Dill\ ~ 
a 
--
-
~ 
Progesterone 17 -llydroxypro gesterone 4-Androstenedione 
[A---78---?C---70 = !5.5 pathway; a---?b---?c = !5.4 pathway] 
Figure 1.3. Biosynthesis ofandrogcn in human. 
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. 
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Oxidation 
H 
Nandrolone N orandrosterone 
OH OH 
Hydroxylation 
Stanozolol 3-Hydroxystanozolol 
Reduction 
17a-Methyltestosterone 17a-Methylandrostandiol 
Figure 1.4. The metabolism of nandrolone, stanozoloL 17a-methyltestosterone and 
their major metabolites in human urine. 
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1.5 Analysis Of Anabolic Steroids In Urine 
1.5.1 Nature of sample for steroid analysis 
,. 
For the analysis of steroids, the biological fluids that can be used are urine, blood, 
plasma and serum. Among all these. only urine has been used in doping control by the 
International Sport Federations. However, blood is also the alternative choice rine 
samples when urine is unavailable since :woo. Untimed urine samples are collected 
from athletes to detennine whether administration of a banned drug has occurred. 
Urine was selected as the biological fluid of choice for athletes for two main reasons. 
First. the collection is non-invasive to the individual and after administration, many 
banned drugs and their metabolites are more concentrated in the urine than in serum. 
Secondly. an untimed collection of urine gives a sufficiently large volume for both a 
full drug screen and a confinnatory analysis (Cowan, 1993/4). 
However, the analysis of anabolic steroids rn unne IS fraught with challenges 
(Bower, 1997). These challenges are: -
(i) The low concentration of anabolic steroid metabolites, in the range of IJ.g/L. 
(ii) The large number of steroids and their metabolites appearing in the urine 
matrix. 
(iii) The complexity of the urine matrix, which contains endogenous steroids of 
similar structure at concentrations of more than 1000-fold higher than the 
compounds of interest. In addition, urine contains large amounts of different 
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types of organic compounds and acids, which often cause problems during 
sample clean-up. 
1.5.2 Sample preparation 
A sample preparation step is necessary in the analysis of drugs in biological fluids to 
isolate the compounds of interest from a sample matrix as well as to purify and 
concentrate the analyte. Various sample preparation methods pnor to 
chromatographic analysis are listed in Table 1.2. However. those commonly used for 
chromatography are extraction methods like liquid-liquid extraction and solid phase 
extraction where the latter represents the more popular method nowadays. 
1.5.2.1 Solvent extraction 
Solvents that are miscible or immiscible with water, such as ethyl acetate, ether, 
chloroform and dichloromethane have long been used to extract free (unconjugated) 
steroids from biological matrices. Analytes are extracted into organic solvents only if 
t~ey possess sufficient lipophilic character to be attracted into a non- polar solvent 
(McDowall, 1989). Solvent polarity is an important consideration when planning a 
solvent extraction. Other factors affecting the choice of solvent for extraction include 
boiling points, density, toxicity and purity. 
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Table 1.2. Sample preparation procedures pnor to chromatographic analysis · 
(Stevenson, 1996; McDowall et al., 1989). 
J. Solvent extraction 
' 
11. Freeze drying 
,., pH Change 13. Enzyme digestion 
... Chemical derivatization .). I4. Hydrolysis 
4. Solid Phase Extraction (SPE) I 5. Column switching 
5. Stearn extraction 16. Low temperature storage 
6. ·Homogenization l 7. Column chroma1ography 
7. Protein precipitation I 8. Microwave assisted extraction 
8. Dialysis I 9. Headspace analysis 
9. Sonication 10. Ultrafiltration 
I 0. Centrifuge 21. Supercritical Fluid Extraction (SFE) 
II. Evaporation 
The choice of solvent for extraction depends on the desired degree of specificity. The 
• most non-polar solvent that completely removes a drug will be the one least likely to 
remove more polar metabolites. In comparison, a more polar solvent will remove both 
the drug and metabolites for separation. 
For an extraction to be successfi.Il, the compounds to be extracted should be un-
ionized to facilitate partition into organic phase. Therefore. adjustment of the pH of 
the medium which the compound is to be extracted from can be used to optimize 
extraction. An optimal pH is selected based on the pKa value of the compound 
'---
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(Schwartz and De Silva. 1979). As a rule, the pH should be 1-2 units below the pKa 
value for acidic drugs and l-2 units above the pKa value for basic drugs. For example, 
the pKa value for an acidic compound having a carboxyl group (R-COOH) is 4.9. 
Thus, in order to extract this compound, tbe pH of the medium should be adjusted to 
" 2.9-3.9 {Simpson. 2000). 
1.5.2.2 Solid Phase Extraction (SPE) 
In solid phase extraction, the biological fluid is first passed through an adsorbent 
(stationary phase) which is usually packed in a small cartridge or column. As the 
sample passes through the stationary phase, the analyte and other endogenous 
substances are bound to the stationary phase by mechanisms which include hydrogen 
bonding, dipole-dipole interactions, hydrophobic dispersion forces and electrostatic 
(ionic) interactions. The analyte and endogenous substances are thus separated 
according to the degree in which they are partitioned or absorbed by the stationary 
phase (McDowall, 1989). The absorbent is subsequently washed with water or a 
suitable solvent to selectively remove the interfering endogenous substances from the 
sample matrix. By further selective elution with an appropriate solvent system, the 
compound of interest is eluted for subsequent analysis. 
The classical adsorbents used in SPE are carbon, Amberlite XAD or alumina. 
However, these have been largely replaced by bonded phase silica such as C 18 or C8 
since 1980s (McDowall, ! 989). With various bonded phases available, the analyst can 
adjust chemical selectivity to maximize extract cleanliness. The more common phases 
are classified as non-polar, polar and ion exchange phases such as cation and anion 
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exchange with mixed retention mechanisms. Usually. mixed phases were prepared 
from mixture of non-polar and ion exchange phases and are used for specific 
applications, e.g. to extract more polar steroids. Affinity phase materials are also 
found to have a role in SPE. The mechanism of SPE is shown in Figure I .5 whereas 
" I 
the schematic of different type of sorbent interactions is shown in Figure 1.6 
(Simpson and Van Horne. I 993). 
1.5.2.3 Hydrolysis of steroids 
A method of hydrolysis is necessary in order to deconjugate the steroid conjugates 
that appear as glucuronides and sulphates during the sample preparation of steroid 
analysis (Bowers and Sanaullah. 1996). This is because of the conjugated steroids are 
very polar and seldom determined directly. 
In general. there are two types of hydrolysis method. These are solvolysis and 
enzymatic hydrolysis. Solvolysis is a method that involves the use of concentrated 
acid such as sulphuric acid or hydrochloric acid for deconjugation of sulphate 
conjugates. In solvolysis,· cleavage of steroid conjugates is rapid by henting the 
conjugates at moderate temperature within a short period of time. However, it has 
gradually become less important because it involves the use of concentrated acid 
(Gower. 1995). Enzymatic. hydrolysis involves the use of P-glucuronidase and 
sulphatase enzyme for cleavage of glucur01:ides and sulphates. In this method, the 
enzymes are heated at moderate temperature such as 60°C for 2 to 8 hours. This 
method is popular in the routine analysis of steroid in most laboratories as it is safer to 
use. However, the shortcoming is that it is time consuming. 
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There are two main sources for the deconjugation enzymes. i.e. E. coli and Helix 
pomatia. E.Coli only possess glucuronidase activity as compared to Helix pomatia 
which possess both glucuronidase and sulphatase activity. Heli.r: pomatia is preferred 
for routine work because it is cheaper as compared to E. coli and it has aryl sulphatase 
'"' 
activity to hydrolyze the sulphate conjugates. thereby enabling complete hydrolysis to 
be achieved (Vanluchene eta! .. 1982; Messeri eta! .. 1984). However, Helix pomatia 
also possess dehydrogenase enzymes which can convert 5-androstenediol and DHA 
that are present in urine sample to testosterone and 4-androstenedione. respectively. 
This may lead to problems in the interpretation of the endogenous urine profiles of 
endogenously excreted steroids. On the other hand, hydrolysis with E. coli will 
produce cleaner extracts than Helix pomatia because there is no sulphatase and other 
oxidase enzyme activity. Therefore. it is preferred for confinnatory analysis. 
- 21-
(a) Compound of interest 
retained. 
(b) 
Interfering substances pass 
through absorbent or are 
subsequently washed off. 
Compound of interest 
eluted from absorbent. 
Figure 1.5. The me~hanism of solid phase extraction (Simpson and Van Horne, 1993). 
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"Non-Polar Interaction·· using Cs (Octylsilane) or C 18 (Octadecylsilane) sorbent 
CIS 
0 
Retention; Facilitated by polar solvent environments 
cs 
CD 
Retention: Facilitated by polar solvent environments E lut1on· Facilitated by non-polar solvent environments 
"Polar Interaction .. using CN (Cyanopropyl)or NH~ (Aminopropyl) sorbent 
Rl!'tention; Facili1:1tcd b~ nt1n-polar .. oh-C"nt en\ ironment Eluunn: Faciluated h) polar Jo(\1\ .. enl environment,. 
Retention: Facilita1ed by non-p<'lat!-OI\erM en\·ironment Elution: F3cilitatc:d by polar sohent en\ ironment 
Figure 1.6. The schematic of different types of sorbent interactions (Simpson and Van 
Home, 1993). 
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"Ionic Interaction" using PRS (Sulfonylpropyl), CBA (Carboxymethyl) or NH2 
(Aminopropyl) sorbent 
PRS 
8 08+ 
-(~49-R 
G 
9 
CBA 
• Retention: Facilitated by solvents:-
(a) having low ionic strength 
(b) containing low selectivity 
counter-ions 
(c) at a pH where both sorbent 
and isolate are charged 
Elution: Facilitated by solvents: -
(a) having high ionic strength 
(b) containing high selectivity 
counter-ions 
(c) at a pH where either the 
sorbent or isolate is neutral 
Figure 1.6. (contd.). The schematic of different type of sorbent interactions (Simpson 
and Van Home. 1993) 
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1.5.2.4 · Irn rnunoassay 
Immunoassay is basically a competitive binding assay utilizing specific binding 
proteins or antibodies. In this ass1y, the analyte of interest is labeled with a 
,., 
I 
radioac.tive tracer or enzyme and competes with the unlabeled analytes or antigens for 
the binding sites of antibodies or binding proteins. The binding that occurs bet\veen 
analytes and proteins is based on antigen-antibody interaction. The percentage of 
radioactivity or enzyme activity contained in the antibody or protein bound fraction is 
inversely related to the concentration of unlabelled analyte or antigen in the standard 
or sample (Butt 1984 ). 
Tf a radioactive tracer is used, the immunoassay is called radioimmunoassay (RIA). 
Alternatively, if an enzyme is used. the immunoassay is then named as an enzyme 
immunoassay (EIA). In RIA, the radioactive tracers (radioisotope) that is usually used 
in many laboratories are 1c5I and 3H. The use of radioisotopes in RIA provides a 
convenient and sensitive immunoassay. However, they produce a health and 
environmental hazard. Another type of RIA is immunoradiometric assay (IRMA). In 
th.is assay, instead of using a labeled antigen, a labeled antibody is used. This method 
is very convenient to carry out but it is Jess sensitive than RIA. Newer enzyme 
immunoassays, e.g. Enzyme Linked Immunosorbent Assay (ELISA) work on the 
same principle except that an enzyme is used as a label. The theory of ELISA is as 
described in section 3.1.3. This met'1od has the advantage that no radioisotope JS 
involved, it is commercially available and comparatively sensitive to RIA. 
